Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.

Mielke MM, Leoutsakos JM, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Tschanz JT, Lyketsos CG. Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. Alzheimers Dement. 2012 May; 8(3):180-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.